Director/PDMR Shareholding

RNS Number : 6828G

Hikma Pharmaceuticals Plc

31 May 2017

 

Hikma Pharmaceuticals PLC - Vesting of LTIP Awards

LONDON, 31 May 2017: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards on 29 May 2017 under the 2005 Long Term Incentive Plan ("LTIP") which was completed on 31 May 2017. These awards were automatically exercised by operation of the conditional award and vesting process. The exercise price under the LTIP is £nil.

Notification and public disclosure of transactions by persons discharging managerial responsibilities

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Said Darwazah
2	Reason for the notification
a)	Position/status	Chairman and Chief Executive Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from vesting of the conditional awards on 29 May 2017 under the 2005 LTIP.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 52,164
d)	Aggregated information	N/A
e)	Date of the transaction	30 May 2017
f)	Place of the transaction	London Stock Exchange (XLON)

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mazen Darwazah
2	Reason for the notification
a)	Position/status	Executive Vice Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from vesting of the conditional awards on 29 May 2017 under the 2005 LTIP.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 38,088
d)	Aggregated information	N/A
e)	Date of the transaction	30 May 2017
f)	Place of the transaction	London Stock Exchange (XLON)

 

END

 

 

DSHGIGDULXXBGRB